Alfagih, I.M.; Almurshedi, A.; Aldosari, B.; Alquadeib, B.; Hajjar, B.; Elwali, H.; ALtukhaim, H.; Alzahrani, E.; Alhumaidan, S.; Alharbi, G.
Pulmonary Delivery of Inhalable Sustained Release Nanocomposites Microparticles Encapsulating Osimertinib for Non-Small Cell Lung Cancer Therapy. Pharmaceutics 2026, 18, 134.
https://doi.org/10.3390/pharmaceutics18010134
AMA Style
Alfagih IM, Almurshedi A, Aldosari B, Alquadeib B, Hajjar B, Elwali H, ALtukhaim H, Alzahrani E, Alhumaidan S, Alharbi G.
Pulmonary Delivery of Inhalable Sustained Release Nanocomposites Microparticles Encapsulating Osimertinib for Non-Small Cell Lung Cancer Therapy. Pharmaceutics. 2026; 18(1):134.
https://doi.org/10.3390/pharmaceutics18010134
Chicago/Turabian Style
Alfagih, Iman M., Alanood Almurshedi, Basmah Aldosari, Bushra Alquadeib, Baraa Hajjar, Hafsa Elwali, Hadeel ALtukhaim, Eman Alzahrani, Sara Alhumaidan, and Ghaida Alharbi.
2026. "Pulmonary Delivery of Inhalable Sustained Release Nanocomposites Microparticles Encapsulating Osimertinib for Non-Small Cell Lung Cancer Therapy" Pharmaceutics 18, no. 1: 134.
https://doi.org/10.3390/pharmaceutics18010134
APA Style
Alfagih, I. M., Almurshedi, A., Aldosari, B., Alquadeib, B., Hajjar, B., Elwali, H., ALtukhaim, H., Alzahrani, E., Alhumaidan, S., & Alharbi, G.
(2026). Pulmonary Delivery of Inhalable Sustained Release Nanocomposites Microparticles Encapsulating Osimertinib for Non-Small Cell Lung Cancer Therapy. Pharmaceutics, 18(1), 134.
https://doi.org/10.3390/pharmaceutics18010134